Provided are fused tricyclic urea compounds of Formulas I, II and III, stereoisomers thereof, and pharmaceutically acceptable salts thereof. The fused tricyclic urea compounds of Formulas I, II and III are useful for inhibiting Raf kinase and/or Raf kinase dimer and for treating disorders mediated thereby.